GlassScriptPhysician profile
Effie E Siomos
NPI 1376589572
$595.60
in general payments reported to CMS, 2019-2025
13 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.87 · 2020: $14.81 · 2021: $58.17 · 2022: $69.85 · 2023: $119 · 2024: $63.84 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171.37 | 2019-2023 | Orilissa |
| Astellas Pharma US INC | $86.02 | 2019-2025 | Veozah |
| Pfizer INC. | $81.87 | 2019-2025 | |
| Ethicon US, LLC | $60.11 | 2022-2025 | Stratafix, Ethicon |
| Merck Sharp & Dohme LLC | $34.62 | 2023-2024 | Gardasil 9, M-M-R II, Varivax |
| Alydia Health | $28.41 | 2021 | |
| Coopersurgical, INC. | $24.86 | 2025 | Paragard T 380a |
| Exeltis, USA INC. | $23.69 | 2025 | Slynd |
| Sumitomo Pharma America, INC. | $19.57 | 2023 | Gemtesa |
| Exact Sciences Corporation | $19.06 | 2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $18.64 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $14.05 | 2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Effie Siomos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.